Patents by Inventor Heui Kwan LEE

Heui Kwan LEE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11752210
    Abstract: Disclosed are a sensitizing composition for thermal cancer therapy using electromagnetic waves and a method of treating cancer using the composition. The sensitizing composition includes a metal ion, a metal ion-bound material, metal ion-noncovalently bound apotransferrin (transferrin), or a metal ion-noncovalently bound apotransferrin derivative. The sensitizing composition enables selective delivery of the metal ion to tumorous tissue when administered in vivo, and thus the generation of heat in tumorous tissue in which the metal ion accumulates is increased upon thermal cancer therapy using electromagnetic waves, thereby maximizing efficacy of thermal cancer therapy using electromagnetic waves in treating cancer.
    Type: Grant
    Filed: November 4, 2022
    Date of Patent: September 12, 2023
    Assignee: JINIS CO., LTD.
    Inventors: Hyeon Jin Kim, Seong Tshool Hong, Hea Jong Chung, Heui Kwan Lee, Hea Guk Cho, Jae Gak Yu
  • Publication number: 20230079782
    Abstract: Disclosed are a sensitizing composition for thermal cancer therapy using electromagnetic waves and a method of treating cancer using the composition. The sensitizing composition includes a metal ion, a metal ion-bound material, metal ion-noncovalently bound apotransferrin (transferrin), or a metal ion-noncovalently bound apotransferrin derivative. The sensitizing composition enables selective delivery of the metal ion to tumorous tissue when administered in vivo, and thus the generation of heat in tumorous tissue in which the metal ion accumulates is increased upon thermal cancer therapy using electromagnetic waves, thereby maximizing efficacy of thermal cancer therapy using electromagnetic waves in treating cancer.
    Type: Application
    Filed: November 4, 2022
    Publication date: March 16, 2023
    Applicant: JINIS CO., LTD.
    Inventors: Hyeon Jin KIM, Seong Tshool HONG, Hea Jong CHUNG, Heui Kwan LEE, Hea Guk CHO, Jae Gak YU
  • Publication number: 20210236637
    Abstract: Disclosed are a sensitizing composition for thermal cancer therapy using electromagnetic waves and a method of treating cancer using the composition. The sensitizing composition includes a metal ion, a metal ion-bound material, “metal ion-noncovalently bound apotransferrin” (transferrin), or a metal ion-noncovalently bound apotransferrin derivative. The sensitizing composition enables selective delivery of the metal ion to tumorous tissue when administered in vivo, and thus the generation of heat in tumorous tissue in which the metal ion accumulates is increased upon thermal cancer therapy using electromagnetic waves, thereby maximizing efficacy of thermal cancer therapy using electromagnetic waves in treating cancer.
    Type: Application
    Filed: March 31, 2021
    Publication date: August 5, 2021
    Applicant: JINIS CO., LTD.
    Inventors: Hyeon Jin KIM, Seong Tshool Hong, Hea Jong Chung, Heui Kwan Lee, Hea Guk Cho, Jae Gak Yu
  • Publication number: 20160310594
    Abstract: A sensitizing composition for thermal cancer therapy using electromagnetic waves. The sensitizing composition increases sensitivity upon treatment of cancer using electromagnetic waves, and includes a metal ion, a metal ion-bound material, “metal ion-noncovalently bound apotransferrin” (transferrin), or a metal ion-noncovalently bound apotransferrin derivative. The sensitizing composition that targets cancer enables selective delivery of the metal ion to tumorous tissue when administered in vivo, and thus the generation of heat in tumorous tissue in which the metal ion accumulates is increased upon thermal cancer therapy using electromagnetic waves, thereby maximizing the efficacy of the thermal cancer therapy using electromagnetic waves in treating cancer. A thermal therapy using the sensitizing composition is effective for treating cancer without pain or side effects and can also be used in combination with chemotherapy, radiation therapy, etc., ultimately increasing the potential to cure cancer.
    Type: Application
    Filed: October 14, 2014
    Publication date: October 27, 2016
    Applicant: JINIS CO., LTD.
    Inventors: Hyeon Jin KIM, Seong Tshool HONG, Hea Jong CHUNG, Heui Kwan LEE, Hea Guk CHO, Jae Gak YU